How to Buy GH Research Stock [2024]

Summary: GH Research, a clinical-stage biopharmaceutical company, is publicly traded on the NASDAQ under the ticker symbol GHRS. In this guide, you will learn how to buy GH Research stock with online brokerage platforms, such as Interactive Brokers.

Best Platform for Worldwide Stock Trading & Investing

Highly trusted multi-asset broker with clients in over 200 countries
Trade on 150 markets globally from a single platform (stocks, ETFs, futures, currencies, crypto & more)
Low commissions starting at $0 with no platform fees or account minimums
Easily fund your account and trade assets in 26 currencies
IBKR pays up to 4.58% interest on cash balances of $10k or more

Up to 4.58% interest on balance*

Get Started

About GH Research

GH Research’s homepage. Source: Ghres.com

GH Research (NASDAQ: GHRS) is a Dublin-based clinical-stage biopharmaceutical company with a mission to radically transform the therapeutic options available for psychiatric and neurological disorders.

Central to their groundbreaking efforts is their exploration into 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, a novel compound with significant potential in addressing Treatment Resistant Depression (TRD). The company’s pioneering product, GH001, offers a unique formulation of 5-MeO-DMT, administered through a proprietary inhalation technique. The strides made with GH001 are promising, a fact underscored by their successful execution of two Phase 1 clinical trials involving healthy participants and a consequential Phase 1/2 trial centered on TRD patients.

In tandem with GH001’s advancements, GH Research is diligently working on its other innovative products: GH002, an intravenous mebufotenin formulation, and GH003, its intranasal counterpart. Both candidates are making their way through preclinical trials, targeting psychiatric and neurological conditions.

GH Research is listed on the Nasdaq Exchange under the ticker GHRS.

How to buy GH Research stock: Step-by-step process

Follow these four steps to buy GH Research stock:

Find an online broker;
Register with your chosen broker and deposit funds to your account;
Buy GHRS stock;
Periodically review your position in the company.

Step 1: Choose a broker

The first step in buying GH Research stock is choosing a reliable and regulated online broker.

Based on our analysis, Interactive Brokers is the best online broker for investing in GHRS and will offer you the following:

Commission-free stock and ETF trading;
Trade stocks on 90+ market centers;
Fractional stock trading;
Earn extra income on fully paid shares;
Lowest financing rates for margin accounts in the industry;
No account minimum.

Best Platform for Worldwide Stock Trading & Investing

Highly trusted multi-asset broker with clients in over 200 countries
Trade on 150 markets globally from a single platform (stocks, ETFs, futures, currencies, crypto & more)
Low commissions starting at $0 with no platform fees or account minimums
Easily fund your account and trade assets in 26 currencies
IBKR pays up to 4.58% interest on cash balances of $10k or more

Up to 4.58% interest on balance*

Get Started

Before we proceed, for investors looking to diversify their psychedelic portfolio, here are several other companies at the forefront of the psychedelic renaissance, including:

Cybin (NYSE: CYBN);
Seelos Therapeutics (NASDAQ: SEEL);
Compass Pathways (NASDAQ: CMPS);
Numinus Wellness (TSX: NUMI);
Mind Medicine (NASDAQ: MNMD).

By branching out into multiple players in this domain, you not only spread risk but also stand to reap benefits from diverse corners of this rapidly unfolding sector.

How to choose the best online broker?

When evaluating brokers, consider the following aspects:

Product offering: Verify that the broker offers access to the Nasdaq Exchange and GHRS;
Cost: Understand the fee structure, including commission rates, spreads, inactivity, and account maintenance fees, as well as any hidden charges;
Regulation and safety: Ensure the broker is authorized by the relevant regulatory bodies and that they have implemented appropriate measures to protect your data and funds;
Fractional shares: Check if the broker offers fractional share trading so you can buy stock by the dollar amount (rather than purchasing full shares). This is particularly beneficial for investors with limited capital or those intending to implement a dollar-cost averaging (DCA) strategy.

Step 2: Open and fund your account

Once you’ve chosen your platform, navigate to the broker’s website or app and look for an option to “open an account.” You’ll typically need to provide personal information, including:

Full name;
Address;
Social Security Number or Tax ID;
Employment information;
Financial information, like your net worth and annual income.

Once your account has been verified, depositing funds is next. Several methods, such as bank transfers, debit or credit cards, and third-party payment services like PayPal (PYPL), will typically be available to you. Remember, always check the clearing time. Some methods might have your funds available instantly, while others might take a few business days.

With your account funded, you are ready to begin investing.

Step 3: Place your order and invest in GHRS

Place your order by following these simple steps:

Step 1: Search for GH Research by using its ticker symbol GHRS;
Step 2: Decide on the order type. The two most common options available to you will be a market order, filled immediately, or a limit order, fulfilled at your predetermined price point;
Step 3: Determine how much you want to invest, whether by the dollar amount or by the number of shares;
Step 4: Before clicking ‘Buy’ or ‘Open Trade,’ review all order details to ensure accuracy. Once satisfied, proceed to submit the order to your broker for execution.

Step 4: Monitor your investment

Regularly review your portfolio. As you become more familiar with the investing landscape, you might want to explore more advanced tools, set up automated investments, or even consult with financial advisors offered by some platforms.

Always remember that all investments come with risks. It’s essential to do thorough research and, if necessary, consult with a financial advisor before making significant investment decisions.

GH Research stock price today

Pros and cons of investing in GH Research

Pros

Innovative focus: GH Research is working on treatments based on the novel compound 5-MeO-DMT, aiming to address TRD. If successful, this could fill a significant gap in the current mental health treatment landscape;
Promising clinical trials: The company’s GH001 has shown notable efficacy, with a single-day dosing regimen achieving ultra-rapid remission in a significant portion of TRD patients during Phase 2 trials;
Diverse pipeline: Apart from GH001, GH Research is also advancing other candidates, such as GH002 and GH003, indicating that the company isn’t reliant on just one product for its future success;
Emerging market: The psychedelic-based therapy market is emerging, and early movers like GH Research could have a competitive advantage if their treatments are approved and commercialized.

Cons

Regulatory challenges: Like all biopharmaceutical companies, GH Research will face regulatory hurdles. Achieving approval from bodies like the Food and Drug Administration (FDA) or European Medicines Agency (EMA) is challenging and uncertain;
Commercialization risks: Even if a drug is approved, there’s no guarantee it will be commercially successful. Market acceptance, pricing, reimbursement, and competition can all influence a drug’s commercial trajectory;
Financial health: As a clinical-stage biopharmaceutical company, GH Research may not have a stable revenue stream until its products are approved and commercialized;
Competitive landscape: The psychedelic therapy space is gaining attention, and GH Research could face stiff competition from other firms, some of which might have more resources;
Clinical risks: Future clinical trials could produce less favorable results than earlier trials, or unforeseen side effects could emerge;
Public perception: Psychedelic-based treatments can face stigma or skepticism from certain segments of the population, potentially influencing adoption rates.

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

FAQs about how to buy GH Research stock

When was GH Research IPO?

GH Research went public through an initial public offering (IPO) in June 2021.